Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

93 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Response to COVID-19 booster vaccinations in seronegative people with multiple sclerosis.
Tallantyre EC, Scurr MJ, Vickaryous N, Richards A, Anderson V, Baker D, Chance R, Evangelou N, George K, Giovannoni G, Harding KE, Hibbert A, Ingram G, Jolles S, Jones M, Kang AS, Loveless S, Moat SJ, Robertson NP, Rios F, Schmierer K, Willis M, Godkin A, Dobson R. Tallantyre EC, et al. Among authors: loveless s. Mult Scler Relat Disord. 2022 Aug;64:103937. doi: 10.1016/j.msard.2022.103937. Epub 2022 Jun 4. Mult Scler Relat Disord. 2022. PMID: 35700625 Free PMC article.
Complement regulator factor H in multiple sclerosis.
Ingram G, Hakobyan S, Loveless S, Robertson N, Morgan BP. Ingram G, et al. Among authors: loveless s. J Cell Biochem. 2011 Oct;112(10):2653-4. doi: 10.1002/jcb.23204. J Cell Biochem. 2011. PMID: 21618592
Site-specific clinical disease onset in multiple sclerosis.
Willis MD, Harding KE, Wardle M, Pickersgill TP, Tomassini V, Loveless S, Robertson NP. Willis MD, et al. Among authors: loveless s. Eur J Neurol. 2015 Apr;22(4):732-5. doi: 10.1111/ene.12564. Epub 2014 Sep 8. Eur J Neurol. 2015. PMID: 25196326
Longitudinal Characterization of Autoantibodies to the Thyrotropin Receptor (TRAb) During Alemtuzumab Therapy: Evidence that TRAb May Precede Thyroid Dysfunction by Many Years.
Muller I, Willis M, Healy S, Nasser T, Loveless S, Butterworth S, Zhang L, Draman MS, Taylor PN, Robertson N, Dayan CM, Ludgate ME. Muller I, et al. Among authors: loveless s. Thyroid. 2018 Dec;28(12):1682-1693. doi: 10.1089/thy.2018.0232. Epub 2018 Dec 4. Thyroid. 2018. PMID: 30351224 Free article.
Detecting and predicting neutralization of alemtuzumab responses in MS.
Saxena G, Moore JM, Jones M, Pryce G, Ali L, Leisegang GR, Vijay V, Loveless S, Robertson NP, Schmierer K, Giovannoni G, Gnananpavan S, Baker D, Tallantyre EC, Kang AS. Saxena G, et al. Among authors: loveless s. Neurol Neuroimmunol Neuroinflamm. 2020 Jun 4;7(4):e767. doi: 10.1212/NXI.0000000000000767. Print 2020 Jul. Neurol Neuroimmunol Neuroinflamm. 2020. PMID: 32499328 Free PMC article.
93 results